Varian Medical Systems

Slides:



Advertisements
Similar presentations
Heavy Ion Cancer Therapy
Advertisements

RapidArc plan verification using ArcCHECK™
Energy deposition and neutron background studies for a low energy proton therapy facility Roxana Rata*, Roger Barlow* * International Institute for Accelerator.
Experience, Expertise and a Commitment to Excellence™
Potential of Cyclotrons
University of Florida, Jacksonville, FL
CONTENTS ARE CONFIDENTIAL ORBITAL THERAPY, LLC Dedicated, self-shielded device for breast.
An Advanced Linear Accelerator Facility for Microelectronic Dose Rate Studies P.E. Sokol and S.Y.Lee Indiana University.
The TrueBeam System ™ Clinic Name Presenter’s name Clinic location
CONNECT EVENT 2015 Product Marketing. © 2015 EXACT | CLOUD SOLUTIONS2.
ECPM 2006, Nice, France, 2-4 November DESIGN STUDIES OF THE 300AMEV SUPERCONDUCTING CYCLOTRON FOR HADRONTHERAPY Mario Maggiore Laboratori Nazionali.
1 Bragg Curve  Protons and Carbon. 2 Application of Range  The localized energy deposition of heavy charged particles can be useful therapeutically.
Design and test of a high-speed beam monitor for hardon therapy H. Pernegger on behalf of Erich Griesmayer Fachhochschule Wr. Neustadt/Fotec Austria (H.
Part 1 Introduction to Radiotherapy and External Beam Radiation Deepak Khuntia, MD Vice President, Medical Affairs Varian Medical Systems.
EXHIBITORS. JL Shepherd & Associates is a provider of instruments for radiation detection instrumentation. The company was formed in 1967 and it principally.
PAMELA Contact Author: CONFORM is an RCUK-funded Basic Technology Programme PAMELA: Concepts Particle Accelerator for MEdicaL Applications K.Peach(JAI,
HIAT 2009, 9 th June, Venice 1 DESIGN STUDY OF MEDICAL CYCLOTRON SCENT300 Mario Maggiore on behalf of R&D Accelerator team Laboratori Nazionali del Sud.
Dr. Michael Peiniger Superconducting RF activities at RI Research Instruments with a focus on EXFEL cavity production.
Total Energy Usage As A Measure of Building Performance 30% Building Energy Savings Through an Energy Lifecycle Approach to Building Construction, Retro-fitting,
ISO 9001 Quality Management System
Front End Test Stand Klystron Commissioning Alan Letchford UKNF Plenary Meeting 22 nd April 2009.
Varian Medical Systems By KJ Neish. History ›Originally incorporated in 1948 as Varian Associates, Inc. ›Changed name to Varian Medical Systems, Inc.
Accreditation and Notification in Poland CEOC CEE meeting, Prague, 8th – 10th April 2014.
The High Intensity Proton Accelerator of the Paul Scherrer Institute.
The GMTA and Entry Strategies for Medtec Innovations in the German Market Dr. Detlev Langmann AKM Innovationsmanagement GmbH.
SPECIALISED CYCLOTRON FOR BEAM THERAPY APPLICATION Yu. G. Alenitsky, A
Peter Spiller, CBM collaboration meeting GSI-Darmstadt 11. February 2004 Status of the future accelerator project.
1 Radiotherapy, hadrontherapy and treatment planning systems. Faiza Bourhaleb INFN-Torino University Med 1er-Morocco  Radiotherapy  Optimization techniques.
The Mathematical Modeling of New Operation Modes of Multi–purpose Isochronous Cyclotrons Authors: I.V.Amirhanov, G.A.Karamysheva, I.N. Kiyan Joint Institute.
Converting PROSCAN CS to EPICS Status Damir Anicic, Paul Scherrer Institute, Villigen, Switzerland For EPICS collaboration meeting 2008, Shanghai,
PROTON LINAC FOR INDIAN SNS Vinod Bharadwaj, SLAC (reporting for the Indian SNS Design Team)
E&I Mission Statement To provide value to our customers, employees, shareholders, suppliers and our community by ensuring that our transactions and interactions.
New Gantry Idea for H + /C 6+ Therapy G H Rees, ASTeC, RAL 4 th September, 2008.
ENLIGHT,12/2/20021 Health and Science, can CERN contribute? The Mission of CERN (1954): “The Organization shall provide for collaboration among European.
Introduction to Radiation Therapy
FrontierScience G.P.1 MATRIX an innovative Pixel Ionization Chamber for Online Monitoring of Hadrontherapy Treatments Giuseppe Pittà.
July PRISM Workshop,ICL Extraction in PAMELA, T.Yokoi Extraction in PAMELA Takeichiro Yokoi (JAI, Oxford University, UK)
Development of a superconducting rotating-gantry for carbon therapy
Dae-Hyun Kim Dept. of Biomedical Engineering The Catholic University of Korea Department of Biomedical Engineering Research Institute.
The Australian Hadron Therapy and Research Facility.
Medical application of proton accelerators
A Partner for life By Jill Corbett. “Varian Medical Systems’ mission is to focus energy on saving lives. Our goal is to help save millions of lives around.
Beam dynamics and linac optics studies for medical proton accelerators
Research and Practical Conference “Accelerators and Radiation technologies for the Futures of Russia” September 2012, Saint-Petersburg Proton Radiation.
M. Munoz April 2, 2014 Beam Commissioning at ESS.
April 17, Dejan TrbojevicFFAG07 -Non-Scaling FFAG gantries1 Non-Scaling FFAG Gantries Introduction: Motives: The most challenging problem in the carbon/proton.
beam delivery with SC magnets
MLL Workshop on Future Science 2019 and beyond, 16.Dec.2015 The accelerator, as seen by.. 1 From LBNL Image Library Collection by Dave Judd and Ronn MacKenzie.
E-beam and X-ray Technologies: innovative solutions
AccMed Accelerators for Medicine
Contingent Workforce: Cerner Quality System & Regulations
ESS Innovation Procurement Workshop
How does a klystron work? TE-MPE Section Meeting Karolina Kulesz
Proton Therapy for Cancer Treatment
Progress in the Application
Highlights from INFN-MED
Injector Cyclotron for a Medical FFAG
Kuanjun Fan Institute of applied electromagnetic engineering
A Design of a Gantry with Superconducting Magnets for 350 MeV Protons
M. D. Anderson Cancer Center Houston, TX
CEPC RF Power Sources System
ADS Accelerator Program in China
How to edit the title slide
MQYY: superconducting Quadrupole magnet for Hl-lhc
Quality and Regulatory Planning – the way forward?
Advanced Research Electron Accelerator Laboratory
Non-invasive Beam Position Monitor Research in HUST-PTF
Center for Magnetic Resonance Research
Physics Design on Injector I
Dipl.-Ing. (FH) Reiner Eidenberger MBA
Presentation transcript:

Varian Medical Systems Particle Therapy GmbH 1 | VARIAN PARTICLE THERAPY

1948 Company founded in 1948 by Russell and Sigurd Varian Varian Medical Systems A Reliable Partner in Proton Therapy Company founded in 1948 by Russell and Sigurd Varian Over 2 billion USD in yearly revenues Over 6 billion USD market capitalization 5,700 employees world-wide 55% market share in global radiation oncology market 1948 2 | VARIAN PARTICLE THERAPY

Varian Medical Systems Product Portfolio – Integrated System Solutions 3 | VARIAN PARTICLE THERAPY

History of Proton Program Commitment History of Proton Program 1992 Varian Develops Proton Treatment Planning 1997 Varian Provides Information Systems for Proton Centers 2007 Varian Purchases ACCEL Instruments 2007 Isochronous Superconducting Cyclotron becomes clinical at PSI 2009 Complete Treatment System Delivered to Rinecker Proton Center Munich, Germany (>1200 patients) 2011 First US ProBeam System Delivered to Scripps Health in San Diego 4 | VARIAN PARTICLE THERAPY

Varian Proton Therapy Projects Project Update Varian Proton Therapy Projects Scripps PT Center Equipment order finalized/booked Q4 FY11 3 Rotational and 2 Fixed Beam Rooms KFMC-King Fahd Medical Center Equipment Order finalized/booked Q2 FY12 3 Rotational and 1 Fixed Beam & 1Eye Tx St Petersburg, Russia 2 Rotational Gantries Univ. of Maryland 4 Rotational and 1 Fixed Beam Rooms Ground breaking occurred April 2012 Georgia Proton Treatment Center (Emory) Purchase Agreement under negotiation 4 Rotational and 1 Fixed Beam Room Signed contract for Mestre, Italy 5 | VARIAN PARTICLE THERAPY

Proton Platform—Overview ProBeam™ Proton Platform—Overview Dynamic PeakTM Scanning Superconducting Cyclotron Big Bore Beam Line 2D Orthogonal & CBCT Eclipse & ARIA Integration 7 | VARIAN PARTICLE THERAPY

Why a Cyclotron? Compact & simple ProBeam™ Accelerator System AC 250 Cyclotron Why a Cyclotron? Compact & simple Continuous, high intensity beam (IMPT) Low activation (Service) Reproducible behavior (Operations) 8 | VARIAN PARTICLE THERAPY

10 | VARIAN PARTICLE THERAPY

Dynamic PeakTM Scanning ProBeam™ Dynamic PeakTM Scanning 2 | VARIAN PARTICLE THERAPY

Dynamic Peak™ Scanning Specifications Range: Up to 37.6 g/cm2 Field size at isocenter: Up to 30 x 40 cm2 Dose compliance: Better than ±2.5% Dose rate: Variable with a maximum of 2 Gy/min in 1 liter volume Layer repainting 5 | VARIAN PARTICLE THERAPY

IMPT Summary Quality of Care Optimum dose conformity Dynamic Peak™ Scanning Intensity Modulated Proton Therapy IMPT Summary Quality of Care Optimum dose conformity Allows adaptive treatments and integrated boosts Workflow Increased efficiency Shorter and more stable treatment times 8 | VARIAN PARTICLE THERAPY

Advanced Development Role and Responsibilities: Developments with high research content Contacts and collaborations with institutes Upcoming new concepts new technologies Patents Technology input to strategic planning 17 | VARIAN ONCOLOGY SYSTEMS

Development Example Development of the 250 MeV ProBeam cyclotron Teams: National Superconducting Cyclotron Lab, Michigan University, US - Baseline design and sc cyclotron design expertise Paul Scherrer Institute, Villigen, CH - First customer, cyclotron operation expertise Kernfysisch Versnelleren Instituut, Groningen, NL, Operation of sc cyclotrons Varian/Accel team, Project management, Regulatory compliance, detailed engineering design teams 17 | VARIAN ONCOLOGY SYSTEMS

Development example Development Process: Design Implementation Test V&V Concept Joined design team at NSCL Commissioning and testat PSI Detailed design at Varian Fabrication 17 | VARIAN ONCOLOGY SYSTEMS

Regulatory Compliance For CE marking Establish certified Quality Management System according to ISO 13485 Engage Notified Body for the assessment of conformity with the requirements of the European Medical Device Directive 93/42/EWG Prepare Documentation of Design and Manufacturing Process. Continuous review of product documentation with the Notified Body Final audit of product and documentation Receive approval from Notified Body to declare CE conformity 17 | VARIAN ONCOLOGY SYSTEMS

Marketing challenges Financing Cost of equippment Cost of building Time to first patient patients per day Operating cost "Integrate into normal Radiation Therapy" 24 | VARIAN ONCOLOGY SYSTEMS

Call for Ideas & Research Accelerator - Cost, Size, Weight, Beam duty factor Gantry - Cost, Size, Weight Beamline - Cost, Size, Weight Scanning - Speed Commissioning - Automation 24 | VARIAN ONCOLOGY SYSTEMS

Thank you! 15 | VARIAN ONCOLOGY SYSTEMS

ProBeam™ Accelerator System AC 250 Cyclotron -- Specifications Beam - Energy 250 MeV Extracted current (max) 800 nA Extraction efficiency ~80% Iron Yoke - Outer diameter 3.1 m Height 1.6 m Weight 90 t SC Magnet - Stored energy 2.5 MJ Central field 2.4 T Max. field at the coil 4 T Operating current 160 A Power of cryocoolers 40 kW RF System - Frequency 72.8 MHz Voltage 80 kV / 130 kV RF power ≤115 kW 9 | VARIAN PARTICLE THERAPY